Salma Khan | Precision Medicine | Best Researcher Award

Posted on by sciencefather

Salma Khan | Precision Medicine | Best Researcher Award

Assoc. Prof. Dr. Salma Khan, Loma Linda University, United States

Assoc. Prof. Dr. Salma Khan is a distinguished physician-scientist specializing in gynecologic oncology and thyroid cancer research. With a Ph.D. from Kumamoto University 🇯🇵 and faculty appointments at Loma Linda University 🏥, she excels in translational cancer biology. Her groundbreaking work on health disparities, molecular oncology, and thyroid cancer genomics has earned her multiple honors, including the 2024 AACR Women Cancer Research Award 🌟. She actively contributes to the American Thyroid Association, NIH peer review panels, and serves on several journal editorial boards 📚. Dr. Khan is also a dedicated mentor and advocate for diversity in science and medicine .

Publication Profile

Google Scholar

Education

Assoc. Prof. Dr. Salma Khan began her academic journey with a Higher Secondary Certificate from Govt. M.M. Ali College, Tangail, Bangladesh (1983–1985). 🎓 She earned her MBBS from Gandhi Medical College, Bhopal, India (1986–1991), followed by an internship at Hamidia Hospital (1991–1992). 🏥 Dr. Khan completed her residency in Obstetrics and Gynecology at IPGMR, Dhaka (1992–1994), and pursued a fellowship at Kumamoto University School of Medicine, Japan (1995–1996). 🌸 Her academic excellence culminated in a Ph.D. in Gynecologic Oncology from Kumamoto University (1996–2000), showcasing her dedication to advancing women’s health.

Awards

Assoc. Prof. Dr. Salma Khan has received numerous accolades throughout her distinguished career. She was honored with the Best Mentor Award by BMANA in 2025 (San Francisco), 2023 (Los Angeles), and 2020 (Dallas). 🌟 In 2024, she received the AACR Women Cancer Research Award and the Best Basic Science Research Award in California. 🎗️ A frequent recipient of Travel Awards from the American Thyroid Association (2016–2023), Dr. Khan also earned top honors at scientific meetings and was a keynote speaker in Japan and Korea (2015). 🌍 Her journey began with prestigious academic scholarships in Bangladesh, India, and Japan.

Research Focus

Assoc. Prof. Dr. Salma Khan focuses her research on cancer biology, with a specialized emphasis on exosomes, survivin biology, and biomarkers for early cancer detection, particularly in prostate and breast cancers. Her groundbreaking studies explore how tumor-derived exosomes contribute to cell signaling, apoptosis inhibition, and metastasis, highlighting survivin as a pivotal player and potential diagnostic marker. Dr. Khan’s work intersects molecular oncology and translational medicine, aiming to bridge lab findings with clinical applications. Her contributions are instrumental in advancing non-invasive diagnostic tools and improving cancer prognosis across diverse populations.

Publication Top Notes

Plasma-derived exosomal survivin, a plausible biomarker for early detection of prostate cancer

Survivin is released from cancer cells via exosomes

Early diagnostic value of survivin and its alternative splice variants in breast cancer

Extracellular, cell-permeable survivin inhibits apoptosis while promoting proliferative and metastatic potential

PTEN promoter is methylated in a proportion of invasive breast cancers

Human villous macrophage-conditioned media enhance human trophoblast growth and differentiation in vitro

Differential MicroRNA‐Signatures in Thyroid Cancer SubtypesProteomic profiling of serum-derived exosomes from ethnically diverse prostate cancer patients

Exosomes secreted from human cancer cell lines contain inhibitors of apoptosis (IAP)

LATS1 phosphorylates forkhead L2 and regulates its transcriptional activity

The emerging role of exosomes in survivin secretion

Curcumin induces pancreatic adenocarcinoma cell death via reduction of the inhibitors of apoptosis

Mario Leporace | Personalized Medicine | Best Innovation Award

Posted on by sciencefather

Mario Leporace | Personalized Medicine | Best Innovation Award

Prof. Dr. Mario Leporace, Hospital and University, Italy

Prof. Dr. Mario Leporace is a distinguished Clinical Radiologist at the Department of Nuclear Medicine and Theragnostics, “Mariano Santo” Hospital, Cosenza, Italy. With expertise in oncologic imaging, hybrid and molecular imaging, and cardiovascular radiology, he is renowned for his advanced diagnostic work using X-ray, CT, MRI, PET/CT, and SPECT/CT. He holds a Master’s in Interventional Oncology and has contributed to over 15 peer-reviewed publications. His professional journey spans top institutions in Rome and Cosenza, marking a career dedicated to innovation in radiology and nuclear medicine.

Publication Profile

Scopus

Education

Prof. Dr. Mario Leporace 🎓 is a distinguished expert in interventional oncology and radiology. In 2022, he earned a Master’s Degree in Interventional Oncology from Fondazione Policlinico Universitario A. Gemelli IRCCS in Rome, with a thesis on thermal ablation of bone metastases 🔥🦴. From 2001 to 2005, he completed his post-graduate certification in Radiology at the University of Rome “Tor Vergata” 🏥, graduating cum laude with a thesis on hybrid imaging 🧠📸. He also obtained his Degree in Medicine and Surgery from the same university (1995–2001), graduating with top honors and a thesis in vascular imaging 🫀🧬.

Experience

Prof. Dr. Mario Leporace 🩺 has an extensive career in radiology and nuclear medicine, showcasing over two decades of dedicated medical service. Since October 2017, he has been serving in the Department of Nuclear Medicine and Theragnostics at “Mariano Santo” Hospital in Cosenza, Italy ⚛️🏥. From May 2016 to September 2017, he worked at the Department of Radiology, “Annunziata” Hospital 🏨. Earlier, from March 2006 to April 2016, he contributed to the European Hospital in Rome, and concurrently, from November 2005 to April 2016, served at the Aurelia Hospital in Rome 🏛️🔬, strengthening his clinical expertise across institutions.

Research Focus

Prof. Dr. Mario Leporace focuses his research on Thermal Ablation with Magnetic Resonance-guided Focused Ultrasound Surgery (MRgFUS) 🔬🧠. His work bridges medical physics and oncological applications, exploring non-invasive treatments that use focused ultrasound energy to thermally ablate tumors with MRI precision guidance 🎯. This technique offers cutting-edge therapeutic possibilities in fields such as oncology, neurology, and women’s health 🧬💡. Prof. Leporace’s contributions advance both the clinical outcomes and technological innovation of MRgFUS, making him a key figure in image-guided therapy, minimally invasive surgery, and cancer treatment research .

Publication Top Notes

The Thermal Ablation with MRgFUS: From Physics to Oncological Applications

Nigatu Gebrehiwot | Precision Medicine | Best Researcher Award

Posted on by sciencefather

Nigatu Gebrehiwot | Precision Medicine | Best Researcher Award

Dr. Nigatu Gebrehiwot, Zhengzhou University, China

Dr. Nigatu Gebrehiwot is a dedicated PhD candidate in Pharmacology at Zhengzhou University, China, specializing in drug safety evaluation. He holds a Master’s in Clinical and Administrative Pharmacy from Xi’an Jiaotong University and a Bachelor of Pharmacy from Mekelle University, where he was recognized as an outstanding student. A published researcher and global presenter, Dr. Gebrehiwot has earned accolades including recognition at ISPOR in Barcelona. He is actively involved in multiple international scientific societies and brings strong expertise in pharmacotherapy, academic writing, and collaborative healthcare research. His work explores methionine metabolism and innovative therapeutic strategies.

Publication Profile

Orcid

Education

Dr. Nigatu Gebrehiwot holds a Master’s degree in Clinical and Administrative Pharmacy from Xi’an Jiaotong University, where his research earned an award at the 21st European Congress ISPOR Health Outcome Research Conference in Barcelona, Spain. 🏅 He also earned a Bachelor’s degree in Pharmacy from Mekelle University, where he was recognized as the most outstanding student in his class. 🎓 His academic achievements reflect his dedication to advancing the field of pharmacy, blending clinical expertise with research excellence. Dr. Gebrehiwot’s work continues to impact the healthcare landscape positively.

Experience

Dr. Nigatu Gebrehiwot is currently a Ph.D. candidate in Pharmacology at the Center for Drug Safety Evaluation and Research, Zhengzhou University, Henan, China, since September 2022. 🎓 Prior to this, he served as the Principal Scientific Officer at the Federal Ministry of Health (FMOH) in Ethiopia from June 2020 to 2021. During his tenure, Dr. Gebrehiwot managed national disease programs and medicines, overseeing the funding and evaluation of treatment guidelines and drug therapy protocols in accordance with Ethiopian legislation and EFDA guidelines. 💊 He also led technical committees focused on antimicrobial therapy, cancer, and chronic disease management.

Awards

Dr. Nigatu Gebrehiwot received a prestigious award for his research abstract at the 21st European Congress ISPOR Health Outcome Research conference in Barcelona, Spain. 🏆 This recognition underscores the significant impact of his work in the field of pharmacology and health outcome research. 🌍 His contributions continue to advance knowledge and influence healthcare practices, making him a respected figure in his field. 💡 Dr. Gebrehiwot’s dedication to research excellence and his ability to address critical health issues have earned him well-deserved acknowledgment on an international stage.

Research Focus

Dr. Nigatu Tadesse’s research primarily focuses on molecular alterations in disease processes, with an emphasis on metabolic pathways and their potential as diagnostic and therapeutic targets. His work on gastric intestinal metaplasia and methionine metabolism sheds light on novel approaches to diagnosis and treatment. Additionally, Dr. Tadesse has contributed significantly to pharmacology, particularly the study of traditional medicines like Dioscorea zingiberensis, investigating its phytochemistry, clinical applications, and toxicity. His research also extends to industrial processes, such as wastewater treatment in diosgenin production. His interdisciplinary work connects biomedicine, pharmacology, and environmental science.

Publication Top Notes

Molecular Alterations in Gastric Intestinal Metaplasia Shed Light on Alteration of Methionine Metabolism: Insight into New Diagnostic and Treatment Approaches

Knowledge, attitude and antibiotic prescribing patterns of medical doctors providing free healthcare in the outpatient departments of public hospitals in Sierra Leone: A national cross-sectional study

Dioscorea zingiberensis C. H. Wright: An overview on its traditional use, phytochemistry, pharmacology, clinical applications, quality control, and toxicity

First total synthesis of a novel amide alkaloid derived from Aconitum taipeicum and its anticancer activity

Methods to treat the industrial wastewater in diosgenin enterprises produced from Diosorea zingiberensis C. H. Wright

Safety investigation on total steroid saponins extracts from Dioscorea zingiberensis C.H. Wright: Sub-acute and chronic toxicity studies on dogs

Zhi-Ming Shao | Precision Medicine | Best Researcher Award

Posted on by sciencefather

Zhi-Ming Shao | Precision Medicine | Best Researcher Award

Prof. Zhi-Ming Shao, Fudan University Shanghai Cancer Center, China

Prof. Zhi-Ming Shao is a distinguished surgical oncologist and global leader in breast cancer research. A graduate of Shanghai Medical University, he chairs the Department of Breast Surgery at Fudan University Shanghai Cancer Center and directs its Breast Cancer Institute. With extensive postdoctoral experience in the U.S. and over 30 years of academic excellence, Prof. Shao has received numerous national honors, including the Chang Jiang Scholar and China’s Most Beautiful Doctor Award. His groundbreaking research, published in top journals like Nature Genetics and Cancer Cell, has significantly advanced precision oncology and breast cancer therapy worldwide.

Publication Profile

Scopus

Education

Prof. Zhi-Ming Shao began his medical journey at Shanghai Medical University, where he earned his Bachelor of Medicine (1980–1985). Driven by a passion for cancer treatment, he pursued a Residency in Surgical Oncology (1985–1990) at the prestigious Fudan University Shanghai Cancer Center. During this period, he also completed his Doctor of Medicine (M.D.) through a Postgraduate Course in Surgical Oncology (1987–1990) at Shanghai Medical University. His comprehensive education laid a strong foundation for his distinguished career in oncology, combining clinical expertise with academic excellence.

Experience

Prof. Zhi-Ming Shao has undergone extensive professional training and leadership roles in oncology. He began as a Postdoctoral Research Fellow (1990–1991) at Wake Forest University, followed by a role as Research Associate (1991–1995) at the University of Maryland Cancer Center. Returning to China, he became Associate Professor (1996–1998) and then Professor (1998–present) at Fudan University Shanghai Cancer Center. Since 2000, he has chaired the Department of Breast Surgery and became Director of the Breast Cancer Institute (2019–present). He also served as Chairman of the 8th Asian Breast Cancer Association (2010–2012) and is now Honorary Chairman of the China Anti-Cancer Association.

Awards

Prof. Zhi-Ming Shao has received numerous prestigious honors and awards throughout his career. In 1998, he was named one of the first batch of distinguished professors of the Chang Jiang Scholars Program. He was awarded the National Science Fund for Distinguished Young Scholars in 2001 and recognized as a Young and Middle-aged Expert with Outstanding Contributions by the Ministry of Health of China in 2004. His accomplishments include the National Prize of Science and Technology Progress (Grade II) in 2005, the National May Day Labor Medal in 2008, and the Chinese Physician Prize in 2020. He was also honored with the 2023 China’s Most Beautiful Doctor Award.

Research Focus

Prof. Zhi-Ming Shao’s research focuses on breast cancer, particularly in the areas of pathogenesis and treatment strategies. His work explores novel therapeutic approaches, such as targeting specific pathways involved in triple-negative breast cancer (TNBC) and HER2-positive breast cancer, as well as developing targeted imaging agents for improved diagnosis. Prof. Shao has contributed significantly to understanding the molecular mechanisms of breast cancer progression and therapy resistance. His studies involve investigating genetic markers, tumor microenvironment interactions, and new treatment combinations. Overall, his research aims to improve clinical outcomes for breast cancer patients, especially in advanced or resistant cases.

Publication Top Notes

Breast cancer: pathogenesis and treatments

Metformin sensitizes triple-negative breast cancer to histone deacetylase inhibitors by targeting FGFR4

LINC01235 Promotes Clonal Evolution through DNA Replication Licensing-Induced Chromosomal Instability in Breast Cancer

Pilot Study of Nectin-4–Targeted PET Imaging Agent 68Ga-FZ-NR-1 in Triple-Negative Breast Cancer from Bench to First-in-Human

Efficacy and safety of neoadjuvant SHR-A1811 with or without pyrotinib in women with locally advanced or early HER2-positive breast cancer: a randomized, open-label, phase II trial

The DRAP1/DR1 Repressor Complex Increases mTOR Activity to Promote Progression and Confer Everolimus Sensitivity in Triple-Negative Breast Cancer

O-GlcNAcylation of MORC2 at threonine 556 by OGT couples TGF-β signaling to breast cancer progression

Symptoms Related to Brachial Plexus Neuropathy After Supraclavicular Irradiation and Boost in Breast Cancer

Prognostic value of metabolic signature on 18F-FDGuptake in breast cancer patients after radiotherapy

TEM8 marks neovasculogenic tumor-initiating cells in triple-negative breast cancer

Henryk Mazurek | Precision Medicine | Best Researcher Award

Posted on by sciencefather

Henryk Mazurek | Precision Medicine | Best Researcher Award

Prof. Henryk Mazurek, National Tuberculosis and Lung Diseases Institute, Department of Pneumonology and Cystic Fibrosis, Poland

Prof. Henryk Mazurek is a distinguished pulmonologist, allergologist, and pediatrician specializing in pediatric pulmonology and respiratory diseases. He serves as the Head of the Department of Pneumonology and Cystic Fibrosis at the National Tuberculosis and Lung Diseases Institute, Poland 🇵🇱. With over 60 original research articles and extensive contributions to medical literature 📚, he has significantly advanced the understanding of chronic respiratory diseases, asthma, and cystic fibrosis. A member of esteemed scientific societies 🌍, he actively collaborates internationally and leads impactful research projects. His work in AI-assisted diagnostics and pulmonary care is shaping the future of respiratory medicine. 🚀

Publication Profile

Scopus

Professional Background

Professor Henryk Mazurek is a distinguished pulmonary disease specialist, allergologist, pediatrician, and pediatric pulmonology expert 🩺. He completed postgraduate studies in respiratory pathophysiology in France 🇫🇷 and holds the title of Full Professor in medical and health sciences 🎓. As an academic, he teaches nursing and postgraduate medical training in pediatrics, allergology, and lung diseases. He has authored and co-authored over 60 original articles, 100+ textbook chapters, and numerous scientific publications 📚. A sought-after lecturer, he shares his expertise at medical conferences, educating physicians and healthcare professionals worldwide 🌍.

Memberships

Prof. Henryk Mazurek is an esteemed member of several prestigious scientific organizations, fostering international collaboration in respiratory medicine 🌍🫁. He holds a combined membership in the European Respiratory Society (ERS) / Polish Respiratory Society, along with memberships in the Polish Society of Allergology and the Polish Society of Pediatric Pulmonology, where he is an honorary member 🎖️. For many years, he contributed to the Scientific Council of the Institute of Tuberculosis and Lung Diseases in Warsaw 🏥. Additionally, he served on the Main Boards of the Polish Society of Allergology (2015-2021) and the Polish Society of Cystic Fibrosis (2014-2018) 📚.

Industry Projects

Prof. Henryk Mazurek has actively contributed to over 50 industry-sponsored clinical trials, showcasing his expertise in applied research 🔬. His consultancy work plays a crucial role in bridging academic research with real-world healthcare applications, particularly in advancing treatment strategies for cystic fibrosis 🫁. Through his collaborations with pharmaceutical and medical device companies 💊🩺, he has successfully translated research findings into clinical practice, improving patient outcomes. His dedication to innovation and evidence-based solutions continues to shape the future of respiratory medicine, reinforcing his impact on both academia and industry. 🌍

Research Focus

Prof. Henryk Mazurek’s research primarily focuses on respiratory diseases 🫁, particularly in cystic fibrosis 🧬, pediatric pulmonology 👶, and ventilator-associated pneumonia 🏥. His work explores innovative AI-facilitated home monitoring 🤖 for cystic fibrosis, childhood asthma treatments 🌬️, and the effects of medications like Gabapentin on post-operative pain 💊. He has also studied risk factors for pneumonia 🦠 and strategies for its prevention in ventilated patients. His expertise lies in pulmonary infections, inflammatory biomarkers, and personalized medicine 🧑‍⚕️. His contributions significantly impact respiratory healthcare, enhancing diagnostic and therapeutic approaches for both pediatric and adult patients.

Publication Top Notes

AI-facilitated home monitoring for cystic fibrosis exacerbations across pediatric and adult populations

Childhood asthma treatment based on indirect hyperresponsiveness test: Randomized controlled trial

The Effects of Gabapentin on Post-Operative Pain and Anxiety, Morphine Consumption and Patient Satisfaction in Paediatric Patients Following the Ravitch Procedure—A Randomised, Double-Blind, Placebo-Controlled, Phase 4 Trial

Risk Factors and Protective Factors against Ventilator-Associated Pneumonia—A Single-Center Mixed Prospective and Retrospective Cohort Study

Automatic continuous control of cuff pressure and subglottic secretion suction used together to prevent pneumonia in ventilated patients—a retrospective and prospective cohort study

Chronic bacterial pulmonary infections in advanced cystic fibrosis differently affect the level of sputum neutrophil elastase, IL-8 and IL-6

Edwin Posadas | Precision Medicine | Best Researcher Award

Posted on by sciencefather

Edwin Posadas | Precision Medicine | Best Researcher Award

Dr. Edwin Posadas, Cedars-Sinai Cancer, United States

Dr. Edwin M. Posadas is a distinguished oncologist and urologist specializing in prostate cancer research and treatment. He is a Professor at Cedars-Sinai Medical Center and UCLA, co-Director of the Cancer Therapeutics Program, and Medical Director of the Urologic Oncology Program. A Johns Hopkins graduate, he trained at the NIH and University of Michigan. Dr. Posadas has earned numerous accolades, including Castle Connolly Top Doctor and Sigma Xi Honors. An active researcher, mentor, and leader in oncology, he contributes to multiple scientific committees and journals, shaping the future of cancer care. 📚🔬✨

Publication Profile

orcid

Education

Dr. Edwin Posadas 🎓 began his academic journey at Johns Hopkins University, earning dual B.E.S. degrees in Biomedical and Chemical Engineering (1993) with summa cum laude honors. His studies focused on biological transport systems and physiological fluid mechanics. He then pursued his M.D. at Johns Hopkins School of Medicine (1998) 🩺, followed by an internship and residency at the University of Michigan Medical Center (2001) 🏥. Further specializing, he completed a fellowship in Medical Oncology and Hematology (2005) 🧬 at the National Cancer Institute & National Heart, Lung, and Blood Institute, solidifying his expertise in cancer research and treatment. 🔬💙

Professional Associations

Dr. Edwin Posadas 🩺 is an esteemed member of numerous professional associations and scholarly societies, reflecting his dedication to oncology, urology, and medical ethics. He joined the American Medical Association (1993) 🏥, Association of Philippine Physicians of America (1998) 🇵🇭, and American College of Physicians (1998) 🩻, later becoming a Fellow (2010) 🎖️. His contributions extend to the American Society of Clinical Oncology (2001) 🧬, American Association for Cancer Research (2001) 🔬, and European Society of Medical Oncology (2012) 🌍. He also actively participates in cancer research initiatives, including the Cancer Moonshot Program (2016) 🚀 and the Medical Oncology Association of Southern California (2022) 🌿.

Achievements

Dr. Edwin Posadas 🩺 has built a distinguished career in internal medicine and medical oncology, dedicated to advancing patient care and cancer research. In 2001, he became certified in Internal Medicine 🏥, laying the foundation for his expertise in diagnosing and managing complex diseases. His passion for oncology led him to further specialize, earning his Medical Oncology certification in 2019 🧬🎗️. With decades of experience, he remains committed to innovative cancer treatments, translational research, and personalized patient care, making significant contributions to the oncology community through clinical practice, research, and professional collaborations. 🔬💙

Research Focus

Dr. Edwin M. Posadas is a distinguished researcher specializing in prostate cancer 🔬, metastasis 🧬, and nanotechnology-based diagnostics 🏥. His work focuses on understanding the molecular determinants of metastasis in prostate cancer, particularly liver and visceral metastases. He has contributed to the development of nanotechnology solutions for early cancer detection 🩸 and circulating tumor cell profiling. His research also explores the role of FYN kinase in cancer growth and motility. With multiple grants from the National Cancer Institute and Congressionally Directed Medical Research Programs, his pioneering work is advancing precision oncology and metastasis prevention in prostate cancer patients. 🎗️

Publication Top Notes

Determinants of Liver Metastasis

A Nanotechnology Solution for Early Detection of Micrometastatic Prostate Cancer After Radical Prostatectomy

A blood test to identify prostate cancer patients at risk for visceral metastasis

Thermoresponsive NanoVelcro CTC Purification System for Prostate Cancer Profiling

FYN Is a Key Regulator of Metastasis in Prostate Cancer

Targeting FYN in Prostate Cancer: A Key Regulator of Growth and Motility

Jose M. Soriano | Precision Medicine | Best Researcher Award

Posted on by sciencefather

Jose M. Soriano | Precision Medicine | Best Researcher Award

Prof Jose M. Soriano, University of Valencia, Spain

Prof. José M. Soriano is a Full Professor at the Faculty of Pharmacy, Universitat de València, specializing in food safety, toxicology, and nutrition. He holds a Ph.D. in Food Safety and Toxicology (2001) and degrees in Pharmacy (1996) and Human Nutrition and Dietetics (2018). He has led over 50 national and international projects and published 199 journal articles. With an impressive citation index of 5,263, Prof. Soriano is also Editor-in-Chief of the Spanish Journal of Human Nutrition and Dietetics and has published 50 books. His research focuses on nutraceutics, food safety, and toxicology. 📚🍏🔬

Publication Profile

Google Scholar

Academic Background

Prof. José M. Soriano holds a doctorate in Food Safety and Toxicology, along with degrees in Pharmacy and Human Nutrition. With extensive experience in pharmacy, food science, and nutrition research, he is a Full Professor at Universitat de València. His expertise covers critical areas such as food safety, toxicology, and nutrition, where he contributes to advancing scientific understanding. Prof. Soriano’s work bridges academia and practical application, ensuring a deep impact on public health and safety. 🍏🔬📚

Research and Innovations

Prof. José M. Soriano is a distinguished researcher with extensive expertise in food safety, nutrition, and toxicology. He has led over 50 national and international projects, significantly advancing scientific understanding in these critical areas. With more than 5,200 citations and 199 publications in renowned journals, his work has made a lasting impact. Prof. Soriano’s involvement in over 20 consultancy and industry projects further highlights the practical application of his research. His contributions continue to shape the fields of food safety and toxicology, ensuring better public health and informed industry practices. 📚🔬🌍🥗🧬

Editorial and Collaborative Roles

Prof. José M. Soriano is a renowned expert in human nutrition and dietetics, currently serving as the Editor-in-Chief of the Spanish Journal of Human Nutrition and Dietetics. Through his leadership and extensive collaborations with prestigious institutions across Africa and Asia, he actively contributes to advancing research and education in the field. Prof. Soriano’s dedication to improving global health, particularly through nutrition, has earned him recognition across continents. His work plays a significant role in fostering knowledge exchange and implementing impactful solutions in diverse healthcare settings. 🌍🍏📚💡👨‍⚕️

Professional Recognition

Prof. José M. Soriano is highly esteemed within the scientific community, evident through his memberships in prestigious organizations like the Spanish Academy of Nutrition and Dietetics and the Academy of Pharmacy of the Valencian Community. His recognition in these influential bodies reflects his significant contributions to the fields of nutrition, dietetics, and pharmacy. Through his work, Prof. Soriano has earned respect and credibility, underscoring his dedication to advancing knowledge and practices in these vital areas. His ongoing involvement with these academies is a testament to his ongoing impact and influence. 👨‍⚕️📚🏅

Research Focus

Based on the provided research publications, the individual appears to focus primarily on food safety and toxicology, with a particular interest in mycotoxins and their effects on human health. Their work spans areas like the toxicity, occurrence, and detoxification of mycotoxins such as aflatoxins, zearalenone, and fumonisins. Additionally, they have explored the mechanisms of action of sphingolipids in toxicity, food contamination, and microbiological quality in food products like lettuce and milk. This researcher is also involved in studies on obesity and nutrition, highlighting their expertise in both food toxicology and clinical nutrition. 🧪🍽️🔬🦠

Publication Top Notes

Review on the toxicity, occurrence, metabolism, detoxification, regulations and intake of zearalenone: an oestrogenic mycotoxin

Mechanism of action of sphingolipids and their metabolites in the toxicity of fumonisin B1

Presence of aflatoxin M1 in pasteurized milk from Morocco

Determination of aflatoxins in peanuts by matrix solid-phase dispersion and liquid chromatography

Assessment of the microbiological quality and wash treatments of lettuce served in University restaurants

Incidence of ochratoxin A in rice and dried fruits from Rabat and Salé area, Morocco

Incidence of microbial flora in lettuce, meat and Spanish potato omelette from restaurants

 

 

Assoc Prof Dr. Muhammad Raza| Medicinal Chemistry|Best Researcher Award

Posted on by sciencefather

Assoc Prof Dr. Muhammad Razal Kotaska| Medicinal Chemistry|Best Researcher Award

Assoc Prof Dr. Muhammad Raza at University of Gujrat,Pakistan

PROFILE  

orcid

 

 

Early Academic Pursuits 🎓

Dr. Muhammad Asam Raza embarked on his academic journey with a strong foundation in the natural sciences. After completing his F.Sc. from the Board of Intermediate and Secondary Education, Gujranwala in 1998, he pursued a B.Sc. in Zoology, Botany, and Chemistry from the University of Punjab, Lahore. His profound interest in chemistry led him to continue his academic endeavors with an M.Sc. in Chemistry from the same institution, where his research centered on “Production of xylanases and cellulases in bioreactor by using Chaetomium thermophile.”

Dr. Raza’s pursuit of higher education took him to GC University, Lahore, where he earned both his M.Phil. and Ph.D. degrees in Chemistry. His M.Phil. research focused on the “Phytochemical and antioxidant screening of Mimusops elengi,” while his Ph.D. dissertation was centered on the “Extraction, structure elucidation, and microbial transformation of protease inhibitors from medicinal plants.” These early research topics highlight his passion for bioactive compounds and natural product chemistry, setting the stage for a career rich in scientific exploration.

Professional Endeavors 👨‍🏫

Dr. Raza’s academic and research career took off when he joined the University of Gujrat in 2011 as an Assistant Professor in the Department of Chemistry. Over the years, he contributed extensively to teaching and research at the institution, shaping the academic futures of numerous students. His dedication and excellence in the field of chemistry led to his promotion to Associate Professor in December 2020.

In addition to his role as a professor, Dr. Raza has held various administrative responsibilities at the University of Gujrat, including serving as the coordinator of the Four Year Degree Program in Chemistry, time table in-charge, and head examiner for the B.Sc./B.S. Program. His involvement in organizing industrial and study tours has further enriched the academic experiences of students, giving them a practical understanding of their field of study.

Contributions and Research Focus 🔬

Dr. Raza’s research portfolio is vast, focusing primarily on bioactive compounds, their purification, synthesis, and characterization. His expertise in chromatographic techniques, such as Thin Layer Chromatography (TLC), Column Chromatography, and High-Performance Liquid Chromatography (HPLC), has led to significant breakthroughs in the purification of bioactive compounds. He is also proficient in Gas Chromatography-Mass Spectrometry (GC-MS), enabling him to identify volatile compounds and elucidate the structures of synthesized and natural products.

His research interests also encompass microbial transformation, enzyme inhibition, antioxidant studies, and kinetic studies of various reactions. He has explored both natural and synthetic compounds for their antimicrobial and enzyme inhibition properties, significantly contributing to the field of medicinal chemistry. Additionally, Dr. Raza’s work on the production and characterization of xylanases and cellulases from fungal cultures demonstrates his expertise in enzyme technology, which holds potential for industrial applications.

Docking studies, using different software, have also been a significant focus in Dr. Raza’s research. This computational approach to studying molecular interactions has opened new avenues in drug design and development, further enhancing his contributions to the chemistry of biologically active molecules.

Accolades and Recognition 🏆

Throughout his career, Dr. Muhammad Asam Raza has received numerous accolades, reflecting his excellence in both academic and research fields. He was awarded a Merit Scholarship in 1997 from the District Council of Hafizabad, which was an early indicator of his potential. Later, he received the Indigenous PhD 5000 Fellowship Program from the Higher Education Commission (HEC) of Pakistan, a prestigious scholarship that supported his doctoral studies. Dr. Raza’s contributions to research were also acknowledged by the Pakistan Council for Science and Technology (PCST) with Research Productivity Awards in 2012 and 2013.

Further recognition of his expertise came when Dr. Raza was approved as a Ph.D. supervisor by the HEC, allowing him to mentor and guide future researchers in their academic pursuits. Additionally, he secured a research project worth half a million rupees from the HEC, demonstrating his ability to attract significant funding for his research endeavors.

Impact and Influence 🌍

Dr. Raza’s impact extends beyond the classroom and laboratory. His active participation in organizing national and international workshops, seminars, and symposiums has significantly contributed to the dissemination of knowledge in the scientific community. He has been instrumental in hosting events such as the “Two Days Interdisciplinary National Workshop on Chromatography & Mass Spectrometry” and the “Two Days International Symposium on Developments in Contemporary Chemistry” at the University of Gujrat.

His administrative roles have also been influential, particularly his contributions as a member of various departmental committees, including the Departmental Doctoral/MPhil Program Committee (DDMPC) and the Purchase Committee (NRPU). Dr. Raza’s participation in such committees highlights his commitment to improving the academic and research infrastructure at the University of Gujrat.

Furthermore, Dr. Raza’s work as a reviewer for scientific journals and project evaluator for research proposals under the NRPU has contributed to maintaining the standards of scientific inquiry in Pakistan. His expertise is frequently sought in assessing research proposals and reviewing academic papers, ensuring the advancement of chemistry research in the country.

Legacy and Future Contributions 🌱

Dr. Muhammad Asam Raza’s contributions to the field of chemistry, both in terms of research and teaching, have left a lasting legacy at the University of Gujrat and beyond. His commitment to advancing knowledge in bioactive compounds, enzyme inhibition, and molecular docking studies is not only reflected in his research but also in the numerous students he has mentored over the years.

Looking forward, Dr. Raza is poised to continue making significant contributions to the field of chemistry, particularly in the areas of natural product chemistry, enzyme technology, and computational drug design. His future work will likely focus on the synthesis and characterization of biologically active compounds, with potential applications in pharmaceuticals, agriculture, and biotechnology.

Dr. Raza’s legacy will undoubtedly be defined by his passion for chemistry, his dedication to teaching, and his tireless pursuit of scientific excellence, which will continue to inspire future generations of researchers.

🎓Publication 

Acetylcholine and butyrylcholine esterase inhibitory potential of newly synthesized halogenated compounds: In vitro, in silico and MD simulation

  • Authors   : emanur Yesilbağ; Muhammad Asam Raza; Zeshan Ali Sandhu; Umme Farwa; Emine Berrin Poyraz;
  • Journal    :Molecular Structure
  • Year         :2025

Advances in the Optimization of Fe Nanoparticles: Unlocking Antifungal Properties for Biomedical Applications

  • Authors   : Sandhu, Z.A.; Raza, M.A.; Alqurashi, A.; Sajid, S.; Ashraf, S.; Imtiaz, K.; Aman, F.; Alessa, A.H.; Shamsi, M.B.; Latif, M.
  • Journal    :Pharmaceutics
  • Year         :2024

Association of APO B gene polymorphisms with the development of myocardial infarction in Pakistani population

  • Authors   : Arshad, M.; Iqbal, R.; Raza, M.; Bashir, R.; Ahmed, T.; Parveen, A.
  • Journal    :Gene
  • Year         :2024

Beyond graphene: exploring the potential of MXene anodes for enhanced lithium–sulfur battery performance

  • Authors   : Zeshan Ali Sandhu; Kainat Imtiaz; Muhammad Asam Raza; Adnan Ashraf; Areej Tubassum; Sajawal Khan; Umme Farwa; Ali Haider Bhalli; Abdullah G. Al-Sehemi
  • Journal    :RSC Advances
  • Year         :2024

Biomedical properties, characterization of seaweeds species and antimicrobial activity,Propriedades biomédicas, caracterização de espécies de algas marinhas e atividade antimicrobiana

  • Authors   : Rizwan, S.; Saleem, M.; Hassan, H.U.; Raza, M.A.; Kanwal, R.; Kabir, M.; Ghaffar, R.A.; Fadladdin, Y.A.J.; Rafiq, N.; Matin, A. et al.
  • Journal    :Brazilian Journal of Biology
  • Year         :2024

Assoc Prof Dr. Karel Kotaska| Precision Medicine |Best Researcher Award

Posted on by sciencefather

Assoc Prof Dr. Karel Kotaska|Precision Medicine|Best Researcher Award

Assoc Prof Dr. Karel Kotaska at University Hospital Motol,Czech Republic

PROFILE  

orcid

 

🎓 Early Academic Pursuits

Kotaška’s academic journey began at the Sladkovského High School in Prague, where he completed his secondary education in 1992. Following this, he embarked on an educational path that laid the foundation for his career in biochemistry. In 1997, he graduated from the Institute of Chemical Technology in Prague, earning a Dipl. Ing. in Chemistry Engineering, specializing in Biomedical Engineering. His thirst for knowledge led him to pursue postgraduate studies at the 2nd Medical Faculty of Charles University, Prague, where he specialized in Biochemistry and Pathobiochemistry, culminating in a Ph.D. in 2003. His doctoral research and thesis defense were pivotal moments in shaping his future career as a leading figure in biochemistry.

🏢 Professional Endeavors

Kotaška’s professional career has spanned over two decades, beginning in 2002 at the Department of Medical Chemistry and Clinical Biochemistry at the University Hospital Motol, one of the largest medical facilities in the Czech Republic. As a research scientist and specialist, he quickly became an integral part of the team, contributing significantly to research projects and clinical laboratory functions. In 2015, Kotaška was appointed Associate Professor in Medical Chemistry and Clinical Biochemistry at the 2nd Medical Faculty of Charles University, further solidifying his standing as an expert in his field. His role expanded into quality management, becoming an auditor and overseeing laboratory processes to ensure adherence to ISO standards and good laboratory practices.

🔬 Contributions and Research Focus

Kotaška’s research interests are broad and impactful, covering various aspects of biochemistry and clinical diagnostics. His primary research focuses on the role of natriuretic peptides in cardiovascular diseases, a field critical for advancing the understanding and treatment of heart-related conditions. He has also made significant strides in investigating biomarkers associated with cardiovascular, neurological, inflammatory, and tumor diseases.

In addition to his contributions to molecular genetics, where he has explored genetic variants linked to diseases, Kotaška is well-versed in laboratory management and external quality control. He has been involved in the harmonization and standardization of laboratory practices, ensuring that diagnostics adhere to global standards. His work in urinalysis and infrared spectroscopy has also pushed forward diagnostic capabilities in clinical biochemistry.

🏆 Accolades and Recognition

Kotaška’s impressive career has not gone unnoticed. He has received numerous grant awards for his research, including projects funded by the Grant Agency of the Ministry of Health (MH) and Charles University. His studies have ranged from investigating biomarkers for organ failure to exploring the molecular biology of neurofibromatosis and cathepsin B activity in bladder carcinoma.

Notably, his project on the biological behavior of urological malignancies, which involved long-term monitoring of tissue, serum, and urine samples, stands out as a pioneering effort in the field of cancer research. Additionally, his ongoing work since 2021 on the effect of combined treatments in chronic heart failure in animal models has further contributed to advancing therapeutic approaches.

🌍 Impact and Influence

Beyond his laboratory work, Kotaška has made substantial contributions to academia and clinical education. Since 2008, he has been involved in teaching postgraduate students and has served as a lecturer at several institutions, including the Czech Technical University, where he taught biomedical engineering and laboratory techniques until 2023. As a member of the education team in postgraduate doctoral studies, he has mentored countless students, helping shape the next generation of biochemists and medical professionals.

Kotaška’s influence extends to his role as a reviewer for several prestigious biomedical journals, such as the Central European Journal of Biology, Open Heart Journal, and Diagnostics. His expertise in statistical methods, including regression analysis, survival analysis, and data evaluation, has positioned him as a thought leader in clinical diagnostics.

📚 Publications and Peer Review

With 66 peer-reviewed publications and 12 book chapters to his name, Kotaška’s work has been widely recognized and cited in the scientific community. His publications span critical topics in clinical biochemistry, genetic research, and molecular diagnostics. His H-index of 10 reflects the significant impact of his research, with 317 citations from scholars and professionals in related fields. His commitment to advancing clinical diagnostics and biochemistry is evident in his body of work, which continues to inform and guide research in these areas.

🏅 Legacy and Future Contributions

Kotaška’s legacy is rooted in his contributions to clinical biochemistry and medical diagnostics. His work on improving diagnostic efficiency, standardizing laboratory procedures, and exploring biomarkers in diseases has set a benchmark in the medical field. As a corresponding member of prominent international organizations, such as the European Federation of Clinical Chemistry and Laboratory Medicine (EFLM) and the International Federation of Clinical Chemistry (IFCC), his influence extends beyond the Czech Republic to the global scientific community.

Karel Kotaška’s future contributions are likely to focus on further enhancing diagnostic tools and treatment methods, particularly in the fields of cardiovascular diseases and cancer research. His ongoing work in investigating the effects of innovative therapeutic treatments for chronic heart failure demonstrates his commitment to improving patient outcomes. Additionally, his leadership in laboratory standardization efforts will continue to shape the practices of clinical laboratories worldwide, ensuring that diagnostics remain accurate, efficient, and globally harmonized.

🌟 Conclusion

Karel Kotaška’s career is a testament to his dedication to advancing medical science and education. His multifaceted contributions as a researcher, educator, and laboratory manager have left a lasting impact on the fields of biochemistry and clinical diagnostics. His work continues to influence both the scientific community and clinical practices, ensuring his legacy as a leading figure in medical chemistry and clinical biochemistry for years to come.

🎓Publication 

Polycyanoacrylate (super glue) as bladder concretion in a patient after bilateral inguinal hernioplasty

  • Authors   : Karel Kotaška; Milan Polák; Antonín Brisuda; Richard Průša
  • Journal    : Annals of Clinical Biochemistry
  • Year         :2020

 

Assoc Prof Dr.Mahmoud Nikseresht, Precision Medicine,Best Researcher Award-1172

Posted on by sciencefather

Assoc Prof Dr.Mahmoud Nikseresht ,Precision Medicine ,Best Researcher Award

Assoc Prof Dr.Mahmoud Nikseresht, at Ilam Branch, Islamic Azad University, Iran

Author Profile

 

Education:

  • Postdoctoral Clinical Research Fellow (2016): Institute of Endocrine Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
    Project: “Detraining-induced alterations in adipokines and cardio-metabolic risk factors after nonlinear periodized resistance and aerobic interval training in obese men.”
  • Ph.D. in Exercise Physiology (2013): Central Tehran Branch, Islamic Azad University, Tehran, Iran.
    Dissertation: “Effects of nonlinear resistance and high-intensity interval aerobic training on resting levels of cytokines in obese men.”
  • Master of Science in Sport and Exercise Physiology (2006): Central Tehran Branch, Islamic Azad University, Tehran, Iran.
    Thesis: “The effects of endurance, plyometrics, and concurrent training on salivary immunoglobulins and bio-energetic characteristics in soccer players.”
  • Bachelor of Science in Physical Education and Sport Sciences (2004): Kharazmi University, Tehran, Iran.

Employment:

  • Associate Professor (2021-present): Department of Exercise Physiology, Islamic Azad University, Ilam Branch.
  • Assistant Professor (2013-2021): Department of Exercise Physiology, Islamic Azad University, Ilam Branch.
  • Instructor (2007-2013): Department of Physical Education and Sport Sciences, Islamic Azad University, Ilam Branch.

Professional Memberships:

  • Member of the European College of Sports Sciences (ECSS) (2010-present)
  • Chair of the ECSS (2018-present)

Publications and Research: Dr. Nikseresht has contributed significantly to the field of exercise physiology through his research and publications. Some of his notable works include:

  • In Progress:

    1. Assessing Physical Activity Levels Among Secondary Students in the West of Iran: A Cohort Study (2023)
    2. Heart Rate and Aerobic Endurance Performance Response during an Incremental Exercise to Exhaustion in Hookah-Smoking Soccer Players (2022)

🎓Publication Top Noted:

Paper Title :Effects of nonlinear resistance and aerobic interval training on cytokines and insulin resistance in sedentary men who are obese

  • Authors   : Mahmoud Nikseresht, Hamid Agha-Alinejad, Mohammad A Azarbayjani, Khosrow Ebrahim
  • Journal    :The Journal of Strength & Conditioning Research
  • Year         : 2014
Paper Title : Detraining-induced alterations in adipokines and cardiometabolic risk factors after nonlinear periodized resistance and aerobic interval training in obese men
    • Authors :   Mahmoud Nikseresht, Mohammad Reza Hafezi Ahmadi, Mehdi Hedayati
    • Journal   : Applied Physiology, Nutrition, and Metabolism
    • Year       : 2016
Paper Title :  Inflammatory markers and adipocytokine responses to exercise training and detraining in men who are obese
  • Authors  :  Mahmoud Nikseresht, Nourkhoda Sadeghifard, Hamid Agha-Alinejad, Khosrow Ebrahim
  • Journal    : The Journal of Strength & Conditioning Research
  • Year         :  2014
Paper Title : Comparison of serum cytokine levels in men who are obese or men who are lean: effects of nonlinear periodized resistance training and obesity
  • Authors  :  Mahmoud Nikseresht
  • Journal   : The Journal of Strength & Conditioning Research
  • Year        :   2018

Paper Title :Comparison of serum interleukin-18 and C-reactive protein levels in obese and non-obese young men: Effects of exercise training and obesity

  • Authors  :  Mahmood Nikseresht
  • Journal   : Journal of Sabzevar University of Medical Sciences
  • Year        : 2018